These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 3570556)

  • 1. W-7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells.
    Lönn U; Lönn S
    Int J Cancer; 1987 May; 39(5):638-42. PubMed ID: 3570556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity.
    Lönn U; Lönn S
    Biochem Biophys Res Commun; 1987 Feb; 142(3):1089-94. PubMed ID: 3103613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of bleomycin lethality by anticalmodulin drugs: a role for calmodulin in DNA repair.
    Chafouleas JG; Bolton WE; Means AR
    Science; 1984 Jun; 224(4655):1346-8. PubMed ID: 6203171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of dacarbazine damage of human neoplastic cell DNA by aphidicolin.
    Lönn U; Lohn S
    Cancer Res; 1987 Jan; 47(1):26-30. PubMed ID: 3098406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin.
    Lönn U; Lönn S
    Biochem Pharmacol; 1988 Sep; 37(18):3441-6. PubMed ID: 2971359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.
    Rosenthal SA; Hait WN
    Yale J Biol Med; 1988; 61(1):39-49. PubMed ID: 2452522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced DNA damage induced in human melanoma cells by dacarbazine in the presence of deoxyribonucleosides.
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Jun; 49(11):2921-4. PubMed ID: 2785848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of mouse preimplantation development: inhibitory effect of the calmodulin antagonist W-7 on the first cleavage.
    Poueymirou WT; Schultz RM
    Mol Reprod Dev; 1990 Jul; 26(3):211-6. PubMed ID: 2115792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
    Hidaka H; Sasaki Y; Tanaka T; Endo T; Ohno S; Fujii Y; Nagata T
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4354-7. PubMed ID: 6945588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calmodulin antagonist W 13 prevents DNA repair after bleomycin treatment of human urological tumor cells growing on extracellular matrix.
    Pavelić K
    Int J Biochem; 1987; 19(11):1091-5. PubMed ID: 2448175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity studies of human melanoma cells and fibroblasts.
    Parsons PG; Brown SG
    Aust J Exp Biol Med Sci; 1979 Apr; 57(2):161-70. PubMed ID: 485982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
    Maynard K; Parsons PG; Cerny T; Margison GP
    Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
    Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
    Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A calmodulin antagonist has no effect on the repair of X-ray-induced damage in a murine mammary carcinoma cell line.
    Ridinger DN; Loh SN; Warters RL; Dethlefsen LA
    Radiat Res; 1986 Nov; 108(2):127-38. PubMed ID: 3786673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
    Kikuchi Y; Iwano I; Kato K
    Biochem Biophys Res Commun; 1984 Aug; 123(1):385-92. PubMed ID: 6541042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
    Smith PJ; Mircheva J; Bleehen NM
    Br J Cancer; 1986 Jan; 53(1):105-14. PubMed ID: 2418859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin antagonists and cAMP inhibit ionizing-radiation-enhancement of double-strand-break repair in human cells.
    Wang Y; Mallya SM; Sikpi MO
    Mutat Res; 2000 Jun; 460(1):29-39. PubMed ID: 10856832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifluoperazine inhibits phagocytosis in a macrophagelike cultured cell line.
    Horwitz SB; Chia GH; Harracksingh C; Orlow S; Pifko-Hirst S; Schneck J; Sorbara L; Speaker M; Wilk EW; Rosen OM
    J Cell Biol; 1981 Dec; 91(3 Pt 1):798-802. PubMed ID: 6120173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effect of interleukin-1 alpha on proliferation through a Ca2+/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1.
    Inokuchi N; Zeki K; Morimoto I; Nakano Y; Fujihira T; Yamashita U; Yanagihara N; Izumi F; Eto S
    Jpn J Cancer Res; 1995 Jul; 86(7):670-6. PubMed ID: 7559085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.